Ibrutinib inhibits BMX-dependent endothelial VCAM-1 expression in vitro and pro-atherosclerotic endothelial activation and platelet adhesion in vivo

© 2022 The Author(s) under exclusive licence to Biomedical Engineering Society.

Bibliographic Details
Main Author: Kohs, Tia C. L. (author)
Other Authors: Olson, Sven R. (author), Pang, Jiaqing (author), Jordan, Kelley R. (author), Zheng, Tony J. (author), Xie, Aris (author), Hodovan, James (author), Muller, Matthew (author), McArthur, Carrie (author), Johnson, Jennifer (author), Sousa, Bárbara B. (author), Wallisch, Michael (author), Kievit, Paul (author), Aslan, Joseph E. (author), Seixas, João D. (author), Bernardes, Gonçalo J. L. (author), Hinds, Monica T. (author), Lindner, Jonathan R. (author), McCarty, Owen J. T. (author), Puy, Cristina (author), Shatzel, Joseph J. (author)
Format: article
Language:eng
Published: 2022
Subjects:
Atherosclerosis
BMX
BTK
Endothelial cell
Ibrutinib
Platelet
TEC
Tyrosine kinase
Online Access:http://hdl.handle.net/10451/53321
Country:Portugal
Oai:oai:repositorio.ul.pt:10451/53321
Description
Summary:© 2022 The Author(s) under exclusive licence to Biomedical Engineering Society.

Similar Items